| Dr Richard O Oyelewu, MD | |
|
701 E. Marshall St, West Chester, PA 19380 | |
| (610) 431-5262 | |
| (484) 337-4082 |
| Full Name | Dr Richard O Oyelewu |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 37 Years |
| Location | 701 E. Marshall St, West Chester, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659345601 | NPI | - | NPPES |
| 001920105 | Medicaid | PA | |
| 232359401 | Other | PA | MAIN LINE HEALTHCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD418850 (Pennsylvania) | Secondary |
| 207R00000X | Internal Medicine | MD418850 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chester County Hospital | West chester, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clinical Care Associates Of The University Of Pennsylvania Health | 4688588866 | 517 |
News Archive
In an unprecedented move, chronic fatigue syndrome patients published a half-page ad in The Washington Post today. The ad brings attention to new, HIV-like retroviruses, including XMRV, which have been linked to CFS and aggressive prostate cancer, and have been detected in healthy blood donors.
People with combined vision and hearing loss are nearly four times more likely to experience depression and more than three times more likely to suffer chronic anxiety, according to a new study published in the journal Frontiers in Psychology and led by Anglia Ruskin University..
Researchers at Indiana University School of Medicine have discovered new information about how a dangerous parasite takes control of a patient's cells as it spreads throughout their body, an important finding that could help in the development of new drugs to treat this infection.
PPD, Inc. has announced the launch of PPD Medical Device, a division of PPD Development, providing services to the medical device industry with experience in developing stents, devices and therapies in the areas of interventional cardiology, endovascular, neurology and orthopedic disorders as well as wound care.
Certara-, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that its Pharsight Consulting Services has developed a mathematical model of tumor growth inhibition, which when combined with baseline prognostic factors, predicts treatment effect with bevacizumab for patients with metastatic colorectal cancer.
› Verified 2 days ago
| Entity Name | Clinical Care Associates Of The University Of Pennsylvania Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972682995 PECOS PAC ID: 4688588866 Enrollment ID: O20031113000301 |
News Archive
In an unprecedented move, chronic fatigue syndrome patients published a half-page ad in The Washington Post today. The ad brings attention to new, HIV-like retroviruses, including XMRV, which have been linked to CFS and aggressive prostate cancer, and have been detected in healthy blood donors.
People with combined vision and hearing loss are nearly four times more likely to experience depression and more than three times more likely to suffer chronic anxiety, according to a new study published in the journal Frontiers in Psychology and led by Anglia Ruskin University..
Researchers at Indiana University School of Medicine have discovered new information about how a dangerous parasite takes control of a patient's cells as it spreads throughout their body, an important finding that could help in the development of new drugs to treat this infection.
PPD, Inc. has announced the launch of PPD Medical Device, a division of PPD Development, providing services to the medical device industry with experience in developing stents, devices and therapies in the areas of interventional cardiology, endovascular, neurology and orthopedic disorders as well as wound care.
Certara-, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that its Pharsight Consulting Services has developed a mathematical model of tumor growth inhibition, which when combined with baseline prognostic factors, predicts treatment effect with bevacizumab for patients with metastatic colorectal cancer.
› Verified 2 days ago
| Entity Name | Chester County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356333579 PECOS PAC ID: 8820084528 Enrollment ID: O20040420001379 |
News Archive
In an unprecedented move, chronic fatigue syndrome patients published a half-page ad in The Washington Post today. The ad brings attention to new, HIV-like retroviruses, including XMRV, which have been linked to CFS and aggressive prostate cancer, and have been detected in healthy blood donors.
People with combined vision and hearing loss are nearly four times more likely to experience depression and more than three times more likely to suffer chronic anxiety, according to a new study published in the journal Frontiers in Psychology and led by Anglia Ruskin University..
Researchers at Indiana University School of Medicine have discovered new information about how a dangerous parasite takes control of a patient's cells as it spreads throughout their body, an important finding that could help in the development of new drugs to treat this infection.
PPD, Inc. has announced the launch of PPD Medical Device, a division of PPD Development, providing services to the medical device industry with experience in developing stents, devices and therapies in the areas of interventional cardiology, endovascular, neurology and orthopedic disorders as well as wound care.
Certara-, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that its Pharsight Consulting Services has developed a mathematical model of tumor growth inhibition, which when combined with baseline prognostic factors, predicts treatment effect with bevacizumab for patients with metastatic colorectal cancer.
› Verified 2 days ago
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053447151 PECOS PAC ID: 6204730955 Enrollment ID: O20150304001436 |
News Archive
In an unprecedented move, chronic fatigue syndrome patients published a half-page ad in The Washington Post today. The ad brings attention to new, HIV-like retroviruses, including XMRV, which have been linked to CFS and aggressive prostate cancer, and have been detected in healthy blood donors.
People with combined vision and hearing loss are nearly four times more likely to experience depression and more than three times more likely to suffer chronic anxiety, according to a new study published in the journal Frontiers in Psychology and led by Anglia Ruskin University..
Researchers at Indiana University School of Medicine have discovered new information about how a dangerous parasite takes control of a patient's cells as it spreads throughout their body, an important finding that could help in the development of new drugs to treat this infection.
PPD, Inc. has announced the launch of PPD Medical Device, a division of PPD Development, providing services to the medical device industry with experience in developing stents, devices and therapies in the areas of interventional cardiology, endovascular, neurology and orthopedic disorders as well as wound care.
Certara-, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that its Pharsight Consulting Services has developed a mathematical model of tumor growth inhibition, which when combined with baseline prognostic factors, predicts treatment effect with bevacizumab for patients with metastatic colorectal cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard O Oyelewu, MD 701 E. Marshall St, West Chester, PA 19380 Ph: (610) 431-5262 | Dr Richard O Oyelewu, MD 701 E. Marshall St, West Chester, PA 19380 Ph: (610) 431-5262 |
News Archive
In an unprecedented move, chronic fatigue syndrome patients published a half-page ad in The Washington Post today. The ad brings attention to new, HIV-like retroviruses, including XMRV, which have been linked to CFS and aggressive prostate cancer, and have been detected in healthy blood donors.
People with combined vision and hearing loss are nearly four times more likely to experience depression and more than three times more likely to suffer chronic anxiety, according to a new study published in the journal Frontiers in Psychology and led by Anglia Ruskin University..
Researchers at Indiana University School of Medicine have discovered new information about how a dangerous parasite takes control of a patient's cells as it spreads throughout their body, an important finding that could help in the development of new drugs to treat this infection.
PPD, Inc. has announced the launch of PPD Medical Device, a division of PPD Development, providing services to the medical device industry with experience in developing stents, devices and therapies in the areas of interventional cardiology, endovascular, neurology and orthopedic disorders as well as wound care.
Certara-, a leading provider of software and scientific consulting services to improve productivity and decision-making from drug discovery through drug development, announced that its Pharsight Consulting Services has developed a mathematical model of tumor growth inhibition, which when combined with baseline prognostic factors, predicts treatment effect with bevacizumab for patients with metastatic colorectal cancer.
› Verified 2 days ago
Dr. Amy Chang, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 Maple Ave, Ste 3, West Chester, PA 19380 Phone: 484-364-2824 Fax: 610-350-3099 | |
Christopher L Baldi, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 Old Fern Hill Rd, Bldg. A Suite 5, West Chester, PA 19380 Phone: 610-696-2850 Fax: 610-696-7159 | |
Dr. Gary Richard Peters, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1235 Great Oak Cir, West Chester, PA 19380 Phone: 610-431-7430 | |
Mr. Vinod Kumar Kataria, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 529 Maple Ave, West Chester, PA 19380 Phone: 610-344-7370 Fax: 610-344-7080 | |
Dr. David E Bobman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 Old Fern Hill Road, Building B Suite 300, West Chester, PA 19380 Phone: 610-431-3122 Fax: 610-431-4799 | |
Dr. Andrew D Sitkoff, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 839 Lincoln Ave Ste A, West Chester, PA 19380 Phone: 610-241-3050 Fax: 610-241-3059 | |
Cheryl A Johnson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 440 E Marshall St, Ste 201, West Chester, PA 19380 Phone: 610-738-2500 Fax: 610-738-2540 |